- Anti-Rheumatic Drugs: Include NSAIDs, corticosteroids, DMARDs, and biologics for inflammation control.
- Anti-Rheumatic Drugs: Used to treat rheumatoid arthritis and slow disease progression.
- Rheumatoid arthritis (RA) is a chronic inflammatory, autoimmune disorder affecting joints and sometimes extra-articular sites.
- Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Slow disease progression, reduce joint destruction and disability.
Classification of Anti-Rheumatic Drug
1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs):
-
- Examples: Ibuprofen, Diclofenac, Naproxen
- Mechanism of Action: Block prostaglandin synthesis by inhibiting COX enzymes, reducing inflammation and pain.
- Use: Symptomatic relief but do not modify disease progression.
- Side Effects: GI ulcers, cardiovascular risks.
2. Corticosteroids (Glucocorticoids):
-
- Examples: Prednisone, Methylprednisolone
- Mechanism of Action: Suppress inflammation and modulate the immune response.
- Use: Short-term management of severe inflammation or flares.
- Side Effects: Osteoporosis, diabetes, infections with long-term use.
3. Disease-Modifying Anti-Rheumatic Drug (DMARDs):
-
- These drugs slow disease progression and prevent joint damage.
- Conventional Synthetic DMARDs:
- Methotrexate: Inhibits dihydrofolate reductase, suppressing T-cell activation. (Most commonly used).
- Leflunomide: Inhibits pyrimidine synthesis, reducing lymphocyte proliferation.
- Sulfasalazine: Anti-inflammatory and immunomodulatory effects.
- Hydroxychloroquine: Inhibits antigen processing and cytokine release.
- Side Effects: Liver toxicity, bone marrow suppression, GI distress, and lung toxicity.
- Biologic DMARDs (Targeted Therapy):
- Target specific immune mediators like TNF-alpha, IL-6, or B-cells.
- Examples:
- TNF Inhibitors: Etanercept, Infliximab, Adalimumab
- IL-6 Inhibitor: Tocilizumab
- B-cell Depleter: Rituximab
- T-cell Inhibitor: Abatacept
- Side Effects: Risk of infections (e.g., tuberculosis reactivation), malignancies, injection site reactions.
- Targeted Synthetic DMARDs (JAK Inhibitors):
- Examples: Tofacitinib, Baricitinib
- Mechanism of Action: Inhibit Janus kinase (JAK) enzymes, blocking cytokine signaling pathways.
- Side Effects: Blood clots, infections, and malignancies.
Key Differences Between Antigout and Anti-Rheumatic Drug:
Feature | Antigout Drugs | Anti-Rheumatic Drugs |
Purpose | Treat gout by lowering uric acid or reducing pain. | Treat rheumatoid arthritis by modifying disease or reducing inflammation. |
Mechanism of Action | Focus on uric acid metabolism or inflammation. | Target immune modulation and inflammation pathways. |
Duration of Therapy | Often long-term for chronic gout management. | Lifelong in most cases for RA to prevent progression. |
Drug Classes | NSAIDs, Colchicine, ULT, Corticosteroids. | NSAIDs, Corticosteroids, DMARDs (synthetic, biologic). |
Thank you for reading from Firsthope's notes, don't forget to check YouTube videos!